Lagi F, Giacomelli A, Borghi V, Ciccullo A, et al. Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study. J Med Virol 2023;95:e29149.
PMID: 37805832